Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2003 | 1 |
2004 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Discovery, Function, and Therapeutic Targeting of Siglec-8.
Cells. 2020 Dec 24;10(1):19. doi: 10.3390/cells10010019.
Cells. 2020.
PMID: 33374255
Free PMC article.
Review.
The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells.
Pogue SL, Preston BT, Stalder J, Bebbington CR, Cardarelli PM.
Pogue SL, et al. Among authors: bebbington cr.
J Interferon Cytokine Res. 2004 Feb;24(2):131-9. doi: 10.1089/107999004322813372.
J Interferon Cytokine Res. 2004.
PMID: 14980077
Item in Clipboard
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
Pan C, Cardarelli PM, Nieder MH, Pickford LB, Gangwar S, King DJ, Yarranton GT, Buckman D, Roscoe W, Zhou F, Salles A, Chen TH, Horgan K, Wang YH, Nguyen T, Bebbington CR.
Pan C, et al. Among authors: bebbington cr.
Cancer Res. 2003 Sep 1;63(17):5526-31.
Cancer Res. 2003.
PMID: 14500390
Item in Clipboard
Cite
Cite